Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cogstate Ltd (AU:CGS)
ASX:CGS
CGS Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.80 - AU$1.44
Previous CloseN/A
Volume30.50K
Average Volume (3M)49.54K
Market Cap
$227.79M
Enterprise ValueAU$148.93M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)20.4
Beta0.46
Next Earnings
Aug 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding171,919,530
10 Day Avg. Volume29,311
30 Day Avg. Volume49,542
Standard Deviation0.17
R-Squared0.05
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.47
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.44Price Target Upside2.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Cogstate Ltd News
PremiumCompany Announcements
Cogstate Ltd’s Record Revenue and Future Prospects
PremiumCompany Announcements
Cogstate Ltd Reports Strong Profit Growth in 2024
PremiumCompany Announcements
Cogstate Ltd Achieves Record Revenue and Strong EBIT Growth in 1H25
PremiumCompany Announcements
Cogstate Ltd to Announce FY25 First Half Results and Host Investor Webcast
PremiumCompany Announcements
Cogstate Ltd Releases 1H25 Financial Performance Update
PremiumCompany Announcements
Cogstate Ltd Announces Cessation of SecuritiesPremiumCompany Announcements
Cogstate Ltd Reduces Shares Through Buyback---
Options Prices
Currently, No data available
---
Ownership Overview
16.96% Insiders
0.42% Mutual Funds
<0.01% Other Institutional Investors
82.62% Public Companies and
Individual Investors
CGS FAQ
What was Cogstate Ltd’s price range in the past 12 months?
Cogstate Ltd lowest share price was AU$0.80 and its highest was AU$1.44 in the past 12 months.
What is Cogstate Ltd’s market cap?
Cogstate Ltd’s market cap is $227.79M.
When is Cogstate Ltd’s upcoming earnings report date?
Cogstate Ltd’s upcoming earnings report date is Aug 26, 2025 which is in 185 days.
How were Cogstate Ltd’s earnings last quarter?
Cogstate Ltd released its earnings results on Feb 19, 2025. The company reported AU$0.036 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.036.
Is Cogstate Ltd overvalued?
According to Wall Street analysts Cogstate Ltd’s price is currently Undervalued.
Does Cogstate Ltd pay dividends?
Cogstate Ltd does not currently pay dividends.
What is Cogstate Ltd’s EPS estimate?
Cogstate Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cogstate Ltd have?
Cogstate Ltd has 171,919,530 shares outstanding.
What happened to Cogstate Ltd’s price movement after its last earnings report?
Cogstate Ltd reported an EPS of AU$0.036 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.855%.
Which hedge fund is a major shareholder of Cogstate Ltd?
Currently, no hedge funds are holding shares in AU:CGS
---
Cogstate Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$1.44 (2.79% Upside)
AU$1.44 (2.79% Upside)
Blogger Sentiment
Bullish
AU:CGS Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.85%
12-Months-Change
Fundamentals
Return on Equity
17.87%
Trailing 12-Months
Asset Growth
16.22%
Trailing 12-Months
Company Description
Cogstate Ltd
Cogstate Ltd is a cognitive science company. The principal activity of the company is a sale of technology and services for the measurement of cognition, where services include scientific consultancy, project management, data management, statistical analysis and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In clinical trials segment, technology and services are sold to pharmaceutical, biotechnology, nutraceutical, and functional food companies.
---
CGS Company Deck
---
CGS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, especially in the clinical trials segment, and strong profit before tax. The successful partnership with Medidata also bodes well for future opportunities. However, the decline in contracted future revenue and healthcare revenue, as well as a reduction in workforce, present some challenges. Overall, the positive aspects, particularly the record revenue and profitable growth, outweigh the negatives.Read More>---
CGS Stock 12 Month Forecast
Average Price Target
AU$1.44
▲(2.79% Upside)
Technical Analysis
CardieX Limited
―
Resonance Health Ltd
―
Race Oncology Ltd.
―
Petratherm Ltd
―
IPH Ltd.
―
Best Analysts Covering CGS
1 Year
1 Year Success Rate
4/12 ratings generated profit
1 Year Average Return
-10.39%
reiterated a buy rating last month
Copying Elyse Shapiro's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -10.39% per trade.
---